While any information concerning mesothelioma, as deadly as it is, and as common as it is becoming, is very difficult to find, I continue to look for more, and I found a few items of interest, so here is the first bit of news that I thought was important:
Researchers at the University of Paris have detected that a multiple of turn CT-scanning technology and severity modulated deviation care (IMRT), well known as scrolled tomotherapy (HT), is more fitting than other deviation methods when it comes to treating mesothelioma after surgery. Mesothelioma is a rare form of cancer of the protective lining of the lungs, heart, trunk and belly that is caused by exposure to asbestos. It develops roughly to one side by enlarged asbestos bearing tumors, and is vey difficult to treat.
Helical tomotherapy offers increased accuracy, and allows oncologists to tailor the deviation sip to the size and shape of the targeted tumor. Mesothelioma tumors tend to be inconsistent in shape and size and expand opposite large sections of the mesothelium, making it extremely difficult for doctors to discharge mesothelioma deviation without destroying large numbers of healthy cells.
The French researchers improved the treatment outcomes of 14 patients with pleural mesothelioma (which especially affects the lungs), who had undergone HT after receiving extrapleural pneumonectomy (EPP)surgery. Two of the patients developed lung inflammation, well known as deviation pneumonitis, but the HT was well tolerated in most of the patients.
After treatment, the mesothelioma returned at a median of 5.1 months in 6 patients, 3 of whom died soon after relapsing. The other 8 survived longer than expected, as most mesothelioma patients live no longer than about 6 months past diagnosis. The median stay of all the study participants was 18.4 months after diagnosis, and patients treated with dyes after that in the trials tended to improve more satisfactorily than those treated with dyes earlier, an outcome attributed to the optimization of dosing parameters amid the doctors administering the radiation.
Please keep in mind that this study was done in France, so some of their wording will probably seem a bit strange. Do ask your oncologist/treatment team to check into this for you, if they have not yet heard about it. Leave no stone unturned - not only will this increase your chances of survival, but it will also help others to receive the most up-to-date treatment options, as well. Best wishes in your search for the truth.
Blessings,
ninib :)
No comments:
Post a Comment